sorbitol 发表于 2025-3-23 13:29:35

http://reply.papertrans.cn/32/3176/317593/317593_11.png

门窗的侧柱 发表于 2025-3-23 17:48:22

Flaws in Antidepressant Research,ed by the pharmaceutical industry to serve its commercial interests. The main objective is to outline the conduct and dissemination of antidepressant trials. The author details the multiple methodological limitations of these studies and further explains how study results are selectively reported an

progestogen 发表于 2025-3-23 21:47:13

Conflicts of Interest in Medicine,issal of harms resulting from medical interventions and the censoring and discrediting of experts questioning the benefit–harm ratio of established healthcare practices. A special emphasis is put on the denial and minimisation of both withdrawal syndromes resulting from physical dependence to antide

Lymphocyte 发表于 2025-3-24 01:51:14

Solutions for Reform,prescribing of antidepressants in self-limiting, non-severe depression. It also makes suggestion as to how medical research, education, and practice can be freed from corporate bias, thus putting public health and patient safety over the commercial interests of the pharmaceutical industry.

驳船 发表于 2025-3-24 03:21:56

http://reply.papertrans.cn/32/3176/317593/317593_15.png

吹牛需要艺术 发表于 2025-3-24 09:46:41

http://reply.papertrans.cn/32/3176/317593/317593_16.png

字谜游戏 发表于 2025-3-24 14:42:02

978-3-030-82589-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

Ardent 发表于 2025-3-24 18:05:06

Environmental Business Channels,This chapter provides a short introduction into the themes of this book and the author’s career in psychiatric research. It details how and why the author started to study the efficacy and safety of antidepressants and the corruption of evidence-based medicine.

Conscientious 发表于 2025-3-24 22:08:09

http://reply.papertrans.cn/32/3176/317593/317593_19.png

中国纪念碑 发表于 2025-3-25 00:18:31

http://reply.papertrans.cn/32/3176/317593/317593_20.png
页: 1 [2] 3 4
查看完整版本: Titlebook: Evidence-biased Antidepressant Prescription; Overmedicalisation, Michael P. Hengartner Book 2022 The Editor(s) (if applicable) and The Aut